The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Patients at Government Wenlock Hospital will now have access to cutting-edge ophthalmology diagnostics with the addition of ...

The beginning of the new CPD cycle means it is time to prepare a new professional development plan (PDP) and sketch out areas ...

Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in ...